Drugs / Autologous Platelet Lysate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07551843 Comparator | Oct 2023 → Dec 2024 | dry eye syndrome | G.Gennimatas General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Platelet Lysate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07551843 ↗ |
| Route | Other | “The resulting PL was aliquoted into sterile containers of 5 ml and 10 ml with a dropper tip, thus ensuring ease of administration to the patients' eyes.” NCT07551843 ↗ |